维普期刊资源整合服务平台（V6.5）

96篇 您的检索式：作者名="Sullivan MW"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Unicompartmental knee replacement:A minimum 15 year follow-up study显示文摘	Squire MW Callaghan JJ Goetz DD Sullivan PM Johnston RC	1999	Clin Orthop1999，367，：	1
2	The fas counterattack in vivo:apoptotic depletion of tumor 2 infiltrating lymphocytes associated with fas ligand expression by human esophageal carcinoma显示文摘	O CONNELL J O SULLIVAN GC	1997	J clin Invest1997，99，：	1
3	Expression of Fas ligand by human gastric adenocarcinoma:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O'Connel J O'Sullivan GC	1999	Gut1999，44，2：	1
4	Ovarian responses in women to recombinant follicle -stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation 显示文摘	Sullivan MW Stewart -Akers A Krasnow JS	1999	J Clin Endocrinol Metab1999，84，：	1
5	( +/- )-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors 显示文摘	Sullivan JP Decker MW Brioni JD Donnelly-Roberts D Anderson DJ Bannon AW	1994	J Pharmacol Exp Ther1994，271，：	1
6	Expression of Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O Connel J O Sullivan GC	1999	Gut1999，44，：	1
7	Fas ligand expression in primary colon adenocarcinomas:evidence that the Fas counter attack is a prevalent mechanism of immune evasion in human colon cancer显示文摘	O' Connell J Bennett MW O' Sullivan GC	1998	J Pathol1998，186，1：	1
8	Efficacy of treat- ment for unexplained infertility 显示文摘	Guzyck DS Sullivan MW Adamson GD	1998	Fertil Steril1998，70，2：	1
9	The Fas counterattack: Cancer as a site of immune privilege 显示文摘	Bennett MW O' Sullivan GC	1999	Immunol Today1999，20，1：	1
10	The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control 显示文摘	Decker MW Meyer MD Sullivan JP	2001	Expert Opin lnvestig Drugs2001，10，10：	1
11	The Fas counter-attack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma 显示文摘	Bennett MW O' Coneell O' Sullivan	1998	J I mmunol1998，160，：	1
12	Expressionof Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in smmach cancer显示文摘	Bennett Mw O'connell J O'sullivan GC	2000	Gut2000，46，5：	1
13	Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial 显示文摘	Guinn DA Atkinson MW Sullivan L	2001	JAMA : the Journal of the American Medical Association2001，286，13：	1
14	The Fas counterattack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma显示文摘	Bennett MW O' Connel J O' Sullivan GC	1998	J Immunol1998，160，：	1
15	Efficacy of treatment for unexplained infertility 显示文摘	Guzick DS Sullivan MW Adanson GD	1998	Fertil Steril1998，70，2：	1
16	The manage- ment of acardiac twins : A conservative approach 显示文摘	Sullivan AE Varner MW Ball RH	2003	Am J Obstet Gyneco12003，189，5：	1
17	Expression of Fas ( CD95/APO21 ) ligand by human gastric adenocarcinomas:a potential mechanismof immune escape in stomach cancer 显示文摘	O' Connel J Bennett MW O' Sullivan GC	1999	Gut1999，44，：	1
18	Expression of Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O'Connell J O'Sullivan GC	1999	Gut1999，44，：	1
19	Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium:a potential mechanism of apoptotic epithelial turnover 显示文摘	O' Connell J O'Sullivan GC	1999	DisEsophagus1999，12，2：	1
20	The Fas counterattack:cancer as a site of immune privilege显示文摘	Bennett MW O′Sullivan GC	1999	Immunology Today1999，20，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示